ASSET PURCHASE AGREEMENT BY AND BETWEEN UNITED THERAPEUTICS CORPORATION AND Y-MABS THERAPEUTICS, INC. December 24, 2020Asset Purchase Agreement • February 19th, 2021 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 24, 2020 (“Effective Date”), by and between United Therapeutics Corporation, a Delaware corporation (“Buyer”), and Y-mAbs Therapeutics, Inc., a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENT BY AND BETWEEN ABBVIE IRELAND UNLIMITED COMPANY AND UNITED THERAPEUTICS CORPORATION August 18, 2015Asset Purchase Agreement • August 19th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 18, 2015 (“Effective Date”), by and between AbbVie Ireland Unlimited Company, a private unlimited company incorporated under the laws of Ireland (“Buyer”), and United Therapeutics Corporation, a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.